Once-daily, 3-day azithromycin versus a three-times-daily, 10-day course of co-amoxiclav in the treatment of adults with lower respiratory tract infections: results of a randomized, double-blind comparative study.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples